Loss of heterozygosity for a chromosome 3 sequence presumably at 3p21 in small cell lung cancer
Related Experiment Video
Updated: Aug 17, 2026

Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
Abstract:
A recombinant DNA fragment detecting a chromosome #3 restriction fragment length polymorphism presumably at p21 was hybridized to HindIII-digested DNA isolated from the leukocytes of 12 patients of small cell lung cancer. Four of them appeared to be heterozygous. Analysis of tumor material from these four patients revealed homozygosity for either one or the other restriction fragment in every case. Our findings suggest the presence on the short arm of chromosome #3 of a recessive mutant cancer gene contributing to the development of small cell lung cancer.
Insights
Researchers identified a recessive cancer gene on chromosome 3 short arm. This gene may contribute to small cell lung cancer development, as tumor cells showed homozygosity for a specific DNA marker.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Small cell lung cancer (SCLC) is a significant cause of cancer mortality.
- Genetic alterations, particularly on chromosome 3, are implicated in SCLC pathogenesis.
- Understanding the genetic basis of SCLC is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the role of chromosome 3 genetic alterations in the development of small cell lung cancer.
- To identify potential tumor suppressor genes or oncogenes on chromosome 3 associated with SCLC.
- To analyze restriction fragment length polymorphisms (RFLPs) on chromosome 3 in SCLC patients.
Main Methods:
- DNA was extracted from leukocytes of 12 small cell lung cancer patients.
- Restriction fragment length polymorphism analysis was performed using HindIII digestion and hybridization with a chromosome 3-specific DNA probe.
- Tumor DNA was analyzed to assess homozygosity or heterozygosity for the identified polymorphism.
Main Results:
- A restriction fragment length polymorphism (RFLP) on chromosome 3, likely at the p21 region, was detected.
- Four out of 12 patients were heterozygous for this RFLP in their leukocyte DNA.
- Tumor DNA analysis revealed that these four patients were homozygous for either one or the other allele of the RFLP, indicating loss of heterozygosity.
Conclusions:
- The findings suggest the presence of a recessive mutant cancer gene on the short arm of chromosome 3.
- This gene is potentially involved in the development of small cell lung cancer.
- Loss of heterozygosity at this locus in tumor cells supports its role as a tumor suppressor gene in SCLC.
More Related Videos
05:17Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
Published on: October 10, 2025
11:50Genome-Wide Mapping of Histone Modifications and Transcription Factor Binding Sites in Neuroendocrine Small Cell Lung Cancer Cell Lines Using CUT&RUN
Published on: April 3, 2026
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...